Velocity Clinical Research

Velocity Clinical Research is a medical clinic in Binghamton, New York. The site conducts clinical trials for a broad range of investigational treatments, including vaccines and medicines developed to treat acne, diabetes, depression, high cholesterol, and migraines. The clinic holds a 4.80 rating from 24 reviews.

The Binghamton location partners with United Health Services (UHS) to provide access to research studies for thousands of patients, including those already established with the practice. All trials are performed in accordance with FDA guidelines and in compliance with GCP. The site has a history of conducting clinical trials in the area, previously operating as Regional Clinical Research and later as part of Meridian Clinical Research before being acquired by Velocity in 2022. Clinical trials at this site are led by board-certified physicians serving as Principal Investigators, supported by a research team trained in clinical research regulations, including HIPAA.

Velocity Clinical Research maintains thorough, well-documented business information available online, and their website is well-optimized for search engines to read cleanly.

Velocity Clinical Research provides professional and caring clinical trial opportunities to the Binghamton community.

Services:

• Conducting clinical trials for investigational treatments
• Partnering with healthcare institutions to advance medical research
• Providing compassionate patient care in clinical trial settings